2009
DOI: 10.1080/00952990903125235
|View full text |Cite
|
Sign up to set email alerts
|

Smoking in Pregnant Women Screened for an Opioid Agonist Medication Study Compared to Related Pregnant and Non-Pregnant Patient Samples

Abstract: Background-Little is known about the prevalence and severity of smoking in pregnant opioid dependent patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
31
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 49 publications
(33 citation statements)
references
References 21 publications
(53 reference statements)
1
31
0
Order By: Relevance
“…It should be noted that our measurements of drug use likely underestimate illicit use in pregnant smokers, as those who were receiving opioidmaintenance therapy (buprenorphine or methadone) were excluded from the current trials as opioids are known to alter smoking rates (e.g., Mello, Mendelson, Sellers, & Kuehnle, 1980). As opioid-maintained pregnant smokers have relatively high rates of illicit drug use (Choo, Huestis, Schroeder, Shin, & Jones, 2004;Haug, Stitzer, & Svikis, 2001;Jones et al, 2009), any trial that excludes them will likely underestimate illicit drug use in pregnant smokers.…”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that our measurements of drug use likely underestimate illicit use in pregnant smokers, as those who were receiving opioidmaintenance therapy (buprenorphine or methadone) were excluded from the current trials as opioids are known to alter smoking rates (e.g., Mello, Mendelson, Sellers, & Kuehnle, 1980). As opioid-maintained pregnant smokers have relatively high rates of illicit drug use (Choo, Huestis, Schroeder, Shin, & Jones, 2004;Haug, Stitzer, & Svikis, 2001;Jones et al, 2009), any trial that excludes them will likely underestimate illicit drug use in pregnant smokers.…”
Section: Discussionmentioning
confidence: 99%
“…Alarmingly high rates of smoking (88-95%) occur in pregnant women concurrently treated with buprenorphine or methadone for an opioid use disorder (Chisolm et al, 2013; Jones et al, 2009). Medication-assisted treatment is recommended to help lessen illicit opioid use and improve pregnancy outcomes in women with an opioid use disorder (Center for Substance Abuse Treatment, 2005; National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…In the general pregnant population, 20-45% of women spontaneously quit smoking upon becoming pregnant (Quinn, Mullen, & Ershoff, 1991; Solomon & Quinn, 2004; Woodby, Windsor, Snyder, Kohler, & Diclemente, 1999), while almost no pregnant women in medication-assisted treatment for an opioid use disorder quit spontaneously (Chisolm et al, 2013; Jones et al, 2009). The American College of Obstetricians and Gynecologists (ACOG) and the U.S. Department of Health and Human Services recommend that obstetrical providers ask all pregnant women about tobacco use and provide pregnancy-tailored counseling based on the “5 A's” counseling model (Albrecht, Phelan, & Melvin, 2011; Fiore et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations